Annual EBITDA:
$138.29M+$28.64M(+26.12%)Summary
- As of today, CORT annual EBITDA is $138.29 million, with the most recent change of +$28.64 million (+26.12%) on December 31, 2024.
- During the last 3 years, CORT annual EBITDA has risen by +$10.33 million (+8.08%).
- CORT annual EBITDA is now at all-time high.
Performance
CORT EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
$10.70M-$16.45M(-60.60%)Summary
- As of today, CORT quarterly EBITDA is $10.70 million, with the most recent change of -$16.45 million (-60.60%) on September 30, 2025.
- Over the past year, CORT quarterly EBITDA has dropped by -$36.40 million (-77.29%).
- CORT quarterly EBITDA is now -77.29% below its all-time high of $47.10 million, reached on September 30, 2024.
Performance
CORT Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$67.44M-$36.40M(-35.05%)Summary
- As of today, CORT TTM EBITDA is $67.44 million, with the most recent change of -$36.40 million (-35.05%) on September 30, 2025.
- Over the past year, CORT TTM EBITDA has dropped by -$77.37 million (-53.43%).
- CORT TTM EBITDA is now -53.43% below its all-time high of $144.81 million, reached on September 30, 2024.
Performance
CORT TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
CORT EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +26.1% | -77.3% | -53.4% |
| 3Y3 Years | +8.1% | -67.3% | -48.0% |
| 5Y5 Years | +21.5% | -57.7% | -50.0% |
CORT EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +26.1% | -77.3% | +175.8% | -53.4% | at low |
| 5Y | 5-Year | at high | +26.1% | -77.3% | +175.8% | -53.4% | at low |
| All-Time | All-Time | at high | +433.9% | -77.3% | +183.4% | -53.4% | +255.7% |
CORT EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $10.70M(-60.6%) | $67.44M(-35.1%) |
| Jun 2025 | - | $27.14M(+599.9%) | $103.84M(-7.7%) |
| Mar 2025 | - | $3.88M(-84.9%) | $112.55M(-18.6%) |
| Dec 2024 | $138.29M(+26.1%) | $25.72M(-45.4%) | $138.29M(-4.5%) |
| Sep 2024 | - | $47.10M(+31.4%) | $144.81M(+12.2%) |
| Jun 2024 | - | $35.85M(+21.0%) | $129.06M(+4.4%) |
| Mar 2024 | - | $29.62M(-8.1%) | $123.61M(+12.8%) |
| Dec 2023 | $109.64M(-5.5%) | $32.24M(+2.9%) | $109.59M(+8.9%) |
| Sep 2023 | - | $31.35M(+3.1%) | $100.59M(-1.3%) |
| Jun 2023 | - | $30.41M(+95.0%) | $101.93M(-1.6%) |
| Mar 2023 | - | $15.59M(-32.9%) | $103.63M(-10.4%) |
| Dec 2022 | $116.08M(-9.3%) | $23.25M(-28.9%) | $115.60M(-10.9%) |
| Sep 2022 | - | $32.69M(+1.8%) | $129.82M(-3.2%) |
| Jun 2022 | - | $32.10M(+16.4%) | $134.13M(-0.4%) |
| Mar 2022 | - | $27.57M(-26.4%) | $134.73M(+5.6%) |
| Dec 2021 | $127.95M(-1.9%) | $37.46M(+1.2%) | $127.54M(+5.3%) |
| Sep 2021 | - | $37.00M(+13.2%) | $121.16M(+10.7%) |
| Jun 2021 | - | $32.70M(+60.4%) | $109.44M(-2.7%) |
| Mar 2021 | - | $20.38M(-34.4%) | $112.51M(-13.7%) |
| Dec 2020 | $130.44M(+14.6%) | $31.07M(+22.9%) | $130.44M(-3.3%) |
| Sep 2020 | - | $25.28M(-29.3%) | $134.94M(-5.8%) |
| Jun 2020 | - | $35.77M(-6.6%) | $143.24M(+8.0%) |
| Mar 2020 | - | $38.31M(+7.7%) | $132.63M(+16.6%) |
| Dec 2019 | $113.78M(+26.8%) | $35.58M(+6.0%) | $113.78M(+10.3%) |
| Sep 2019 | - | $33.58M(+33.5%) | $103.17M(+11.4%) |
| Jun 2019 | - | $25.16M(+29.3%) | $92.62M(+5.1%) |
| Mar 2019 | - | $19.46M(-22.0%) | $88.15M(-1.8%) |
| Dec 2018 | $89.73M(+69.4%) | $24.97M(+8.4%) | $89.73M(+3.7%) |
| Sep 2018 | - | $23.03M(+11.3%) | $86.51M(+12.1%) |
| Jun 2018 | - | $20.69M(-1.7%) | $77.14M(+11.4%) |
| Mar 2018 | - | $21.04M(-3.2%) | $69.25M(+30.8%) |
| Dec 2017 | $52.96M(+415.9%) | $21.75M(+59.2%) | $52.96M(+46.2%) |
| Sep 2017 | - | $13.66M(+6.7%) | $36.24M(+41.2%) |
| Jun 2017 | - | $12.80M(+169.4%) | $25.67M(+78.3%) |
| Mar 2017 | - | $4.75M(-5.3%) | $14.40M(+40.3%) |
| Dec 2016 | $10.27M(+412.2%) | $5.02M(+62.3%) | $10.27M(+95.7%) |
| Sep 2016 | - | $3.09M(+101.9%) | $5.24M(+129.7%) |
| Jun 2016 | - | $1.53M(+147.5%) | $2.28M(+737.7%) |
| Mar 2016 | - | $619.00K(+368.9%) | -$358.00K(+95.5%) |
| Dec 2015 | -$3.29M(+88.0%) | - | - |
| Sep 2015 | - | $132.00K(+111.9%) | -$8.01M(+39.4%) |
| Jun 2015 | - | -$1.11M(+72.2%) | -$13.20M(+29.2%) |
| Mar 2015 | - | -$3.99M(-31.3%) | -$18.64M(+32.2%) |
| Dec 2014 | -$27.48M | -$3.04M(+40.0%) | -$27.48M(+20.2%) |
| Sep 2014 | - | -$5.06M(+22.6%) | -$34.45M(+11.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2014 | - | -$6.54M(+49.0%) | -$39.10M(+9.7%) |
| Mar 2014 | - | -$12.83M(-28.2%) | -$43.32M(-4.6%) |
| Dec 2013 | -$41.42M(-14.3%) | -$10.01M(-3.0%) | -$41.42M(-0.1%) |
| Sep 2013 | - | -$9.72M(+9.7%) | -$41.39M(-5.2%) |
| Jun 2013 | - | -$10.76M(+1.5%) | -$39.33M(-8.8%) |
| Mar 2013 | - | -$10.93M(-9.6%) | -$36.15M(+0.3%) |
| Dec 2012 | -$36.24M(-12.1%) | -$9.98M(-30.3%) | -$36.24M(-0.1%) |
| Sep 2012 | - | -$7.66M(-0.9%) | -$36.20M(-3.5%) |
| Jun 2012 | - | -$7.59M(+31.2%) | -$34.98M(+3.5%) |
| Mar 2012 | - | -$11.03M(-11.1%) | -$36.26M(-12.2%) |
| Dec 2011 | -$32.33M(-24.6%) | -$9.93M(-54.2%) | -$32.33M(-7.0%) |
| Sep 2011 | - | -$6.44M(+27.4%) | -$30.23M(+2.2%) |
| Jun 2011 | - | -$8.87M(-24.9%) | -$30.89M(-8.5%) |
| Mar 2011 | - | -$7.10M(+9.3%) | -$28.47M(-3.8%) |
| Dec 2010 | -$25.93M(-28.1%) | -$7.82M(-10.1%) | -$27.43M(-10.7%) |
| Sep 2010 | - | -$7.10M(-10.3%) | -$24.77M(-10.9%) |
| Jun 2010 | - | -$6.44M(-6.3%) | -$22.33M(-7.5%) |
| Mar 2010 | - | -$6.06M(-17.4%) | -$20.77M(-2.6%) |
| Dec 2009 | -$20.24M(-2.9%) | -$5.16M(-10.6%) | -$20.24M(+4.0%) |
| Sep 2009 | - | -$4.67M(+4.4%) | -$21.09M(+1.1%) |
| Jun 2009 | - | -$4.88M(+11.8%) | -$21.32M(-0.9%) |
| Mar 2009 | - | -$5.53M(+8.0%) | -$21.13M(-7.4%) |
| Dec 2008 | -$19.68M(-60.9%) | -$6.01M(-22.8%) | -$19.68M(-8.8%) |
| Sep 2008 | - | -$4.90M(-4.6%) | -$18.08M(-7.7%) |
| Jun 2008 | - | -$4.68M(-14.8%) | -$16.79M(-22.7%) |
| Mar 2008 | - | -$4.08M(+7.6%) | -$13.69M(-11.9%) |
| Dec 2007 | -$12.23M(+52.2%) | -$4.42M(-22.2%) | -$12.23M(-3.6%) |
| Sep 2007 | - | -$3.61M(-129.3%) | -$11.80M(+19.9%) |
| Jun 2007 | - | -$1.58M(+40.0%) | -$14.73M(+30.6%) |
| Mar 2007 | - | -$2.63M(+34.2%) | -$21.22M(+17.0%) |
| Dec 2006 | -$25.57M(-25.0%) | -$3.99M(+39.1%) | -$25.57M(+5.6%) |
| Sep 2006 | - | -$6.55M(+18.8%) | -$27.08M(-31.9%) |
| Jun 2006 | - | -$8.06M(-15.5%) | -$20.54M(-64.6%) |
| Mar 2006 | - | -$6.98M(-26.8%) | -$12.48M(-10.5%) |
| Dec 2005 | -$20.45M(-41.7%) | -$5.50M(+4.9%) | -$11.29M(+41.4%) |
| Mar 2005 | - | -$5.79M(-4.8%) | -$19.26M(-20.0%) |
| Dec 2004 | -$14.44M(-45.1%) | -$5.52M(-29.7%) | -$16.04M(-13.9%) |
| Sep 2004 | - | -$4.26M(-15.3%) | -$14.09M(-17.5%) |
| Jun 2004 | - | -$3.69M(-43.8%) | -$11.99M(-6.9%) |
| Mar 2004 | - | -$2.57M(+28.0%) | -$11.21M(+21.6%) |
| Dec 2003 | -$9.95M(+47.1%) | -$3.57M(-65.4%) | -$14.30M(-33.2%) |
| Sep 2003 | - | -$2.16M(+26.1%) | -$10.73M(-25.1%) |
| Jun 2003 | - | -$2.92M(+48.5%) | -$8.58M(-51.5%) |
| Mar 2003 | - | -$5.66M | -$5.66M |
| Dec 2002 | -$18.80M(-134.8%) | - | - |
| Dec 2001 | -$8.01M | - | - |
FAQ
- What is Corcept Therapeutics Incorporated annual EBITDA?
- What is the all-time high annual EBITDA for Corcept Therapeutics Incorporated?
- What is Corcept Therapeutics Incorporated annual EBITDA year-on-year change?
- What is Corcept Therapeutics Incorporated quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Corcept Therapeutics Incorporated?
- What is Corcept Therapeutics Incorporated quarterly EBITDA year-on-year change?
- What is Corcept Therapeutics Incorporated TTM EBITDA?
- What is the all-time high TTM EBITDA for Corcept Therapeutics Incorporated?
- What is Corcept Therapeutics Incorporated TTM EBITDA year-on-year change?
What is Corcept Therapeutics Incorporated annual EBITDA?
The current annual EBITDA of CORT is $138.29M
What is the all-time high annual EBITDA for Corcept Therapeutics Incorporated?
Corcept Therapeutics Incorporated all-time high annual EBITDA is $138.29M
What is Corcept Therapeutics Incorporated annual EBITDA year-on-year change?
Over the past year, CORT annual EBITDA has changed by +$28.64M (+26.12%)
What is Corcept Therapeutics Incorporated quarterly EBITDA?
The current quarterly EBITDA of CORT is $10.70M
What is the all-time high quarterly EBITDA for Corcept Therapeutics Incorporated?
Corcept Therapeutics Incorporated all-time high quarterly EBITDA is $47.10M
What is Corcept Therapeutics Incorporated quarterly EBITDA year-on-year change?
Over the past year, CORT quarterly EBITDA has changed by -$36.40M (-77.29%)
What is Corcept Therapeutics Incorporated TTM EBITDA?
The current TTM EBITDA of CORT is $67.44M
What is the all-time high TTM EBITDA for Corcept Therapeutics Incorporated?
Corcept Therapeutics Incorporated all-time high TTM EBITDA is $144.81M
What is Corcept Therapeutics Incorporated TTM EBITDA year-on-year change?
Over the past year, CORT TTM EBITDA has changed by -$77.37M (-53.43%)